CellFE

CellFE is a cell engineering startup that enables development and manufacturing of the new generation of medicines cell therapies. CellFE has developed a unique microfluidic platform to solve one of the most pressing issues of therapeutic cell engineering efficiently delivering gene-editing molecules into cells while preserving cell viability. CellFEs technology: Enables development of previously inaccessible cell therapies by providing means for transporting hard-to-deliver molecules into the cells. Accelerates commercialization of existing cell therapies by significantly reducing cost, complexity, and processing time, while improving the efficacy and safety of the cell engineering process

Microfluidics,biotech,cell engineering,crispr/cas9,mrna,plasmid,gene therapies,viral vectors,cell therapies,high throughput technology,bioprocessing,cancer therapies,gene editing,and medical devices

Cellfe operates in the Biotechnology industry.

Cellfe's revenue is 11m - 100m

Cellfe has 11 - 50 employees.